Among HIV-positive patients, ART use, CD4 count, and HIV RNA at lymphoma diagnosis are comparable to contemporary HIV-associated NHL cohorts in the US, as are outcomes for patients treated with CHOP. The gene discussed is CD4; the disease is non-Hodgkin lymphoma.